Gemina Laboratories to Host Investor Webinar on March 30, 2023
VANCOUVER, BC / ACCESSWIRE / March 27, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce that it will host...
Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon
VANCOUVER, BC / ACCESSWIRE / January 10, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide the following strategic overview...
Gemina Labs Completes Influenza A/B Diagnostic Test Prototype
VANCOUVER, BC / ACCESSWIRE / January 6, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the completion of its...